Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
The entity will undertake the installation, operation, and maintenance of sewage treatment plants
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
The lab will facilitate the development of herbal and natural-based solutions
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
Subscribe To Our Newsletter & Stay Updated